The efficacy and safety characteristics of long-term pregabalin treatment of neuropathic pain (NeP) associated with diabetic peripheral neuropathy (DPN) and postherpetic neuralgia (PHN) in treatment-refractory patients: Findings from an open-label trial

被引：0
|
作者：
D'Urso-De Cruz, E
Dworkin, R
Stacey, B
Siffert, J
Fukui, A
Emir, B
机构：
[1] Pfizer Inc, Pfizer Global Pharmaceut, New York, NY USA
[2] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY USA
[3] Oregon Hlth & Sci Univ, Dept Anesthesiol, Portland, OR USA
[4] Pfizer Australia, Pfizer Global Pharmaceut, Sydney, NSW, Australia
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2005年 / 238卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S497 / S498
页数：2
相关论文
共 50 条
  • [31] Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial
    Wernicke, Joachim F.
    Raskin, Joel
    Rosen, Amy
    Pritchett, Yili L.
    D'Souza, Deborah N.
    Iyengar, Smriti
    Knopp, Kelly
    Le, Trong K.
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2006, 67 (05): : 283 - 304
  • [32] LONG-TERM EFFICACY OF PREGABALIN TREATMENT IN PATIENTS WITH PARTIAL-ONSET EPILEPSY: POOLED ANALYSIS OF SIX LONG-TERM, OPEN-LABEL CLINICAL STUDIES
    Emir, B.
    Bazil, C.
    Uthman, B.
    Leon, T.
    EPILEPSIA, 2009, 50 : 198 - 198
  • [33] Efficacy and Safety of 5% Lidocaine (Lignocaine) Medicated Plaster in Comparison with Pregabalin in Patients with Postherpetic Neuralgia and Diabetic Polyneuropathy Interim Analysis from an Open-Label, Two-Stage Adaptive, Randomized, Controlled Trial
    Baron, Ralf
    Mayoral, Victor
    Leijon, Goran
    Binder, Andreas
    Steigerwald, Ilona
    Serpell, Michael
    CLINICAL DRUG INVESTIGATION, 2009, 29 (04) : 231 - 241
  • [34] INTERIM LONG-TERM SAFETY/EFFICACY OF RISANKIZUMAB TREATMENT IN CROHN'S DISEASE PATIENTS FROM THE OPEN-LABEL EXTENSION STUDY
    Ferrante, M.
    Panes, J.
    Baert, F.
    Louis, E.
    Kaser, A.
    Gustafson, D.
    Hall, D.
    Boecher, W. O.
    Herichova, I.
    Liao, X.
    Wallace, K.
    Kalabic, J.
    D'Haens, G.
    GUT, 2019, 68 : A64 - A64
  • [35] Efficacy and safety of add-on mirogabalin to conventional therapy for the treatment of peripheral neuropathic pain after thoracic surgery: the multicenter, randomized, open-label ADMIT-NeP study
    Miyazaki, Takuro
    Matsumoto, Keitaro
    Sato, Toshihiko
    Sano, Isao
    Furukawa, Katsuro
    Shimoyama, Koichiro
    Kamohara, Ryotaro
    Suzuki, Makoto
    Kondou, Masamichi
    Ikeda, Norihiko
    Tabata, Shunsuke
    Shiosakai, Kazuhito
    Nagayasu, Takeshi
    BMC CANCER, 2024, 24 (01)
  • [36] Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
    Ruperto, Nicolino
    Lovell, Daniel J.
    Cuttica, Ruben
    Woo, Patricia
    Meiorin, Silvia
    Wouters, Carine
    Silverman, Earl D.
    Balogh, Zsolt
    Henrickson, Michael
    Davidson, Joyce
    Foeldvari, Ivan
    Imundo, Lisa
    Simonini, Gabriele
    Oppermann, Joachim
    Xu, Stephen
    Shen, Yaung-Kaung
    Visvanathan, Sudha
    Fasanmade, Adedigbo
    Mendelsohn, Alan
    Martini, Alberto
    Giannini, Edward H.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (04) : 718 - 722
  • [37] Long-term efficacy & safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis: Findings from an open-label treatment extension.
    Lovell, D. J.
    Ruperto, N.
    Cuttica, R.
    Woo, P.
    Espada, G.
    Wouters, C.
    Silverman, E. D.
    Balogh, Z.
    Henrickson, M.
    Davidson, J.
    Foeldvari, I.
    Imundo, L.
    Simonini, G.
    Oppermann, J.
    Shen, Y. K.
    Visvanathan, S.
    Fasanmade, A.
    Mendelsohn, A.
    Giannini, E. H.
    Martini, A.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S632 - S632
  • [38] Efficacy and safety of add-on mirogabalin to conventional therapy for the treatment of peripheral neuropathic pain after thoracic surgery: the multicenter, randomized, open-label ADMIT-NeP study
    Takuro Miyazaki
    Keitaro Matsumoto
    Toshihiko Sato
    Isao Sano
    Katsuro Furukawa
    Koichiro Shimoyama
    Ryotaro Kamohara
    Makoto Suzuki
    Masamichi Kondou
    Norihiko Ikeda
    Shunsuke Tabata
    Kazuhito Shiosakai
    Takeshi Nagayasu
    BMC Cancer, 24
  • [39] LONG-TERM SAFETY OF PREGABALIN TREATMENT IN PATIENTS WITH PARTIAL-ONSET SEIZURES: POOLED ANALYSIS OF SIX OPEN-LABEL CLINICAL STUDIES
    Schulze-Bonhage, A.
    Uthman, B.
    Bazil, C.
    Whalen, E.
    Leon, T.
    Emir, B.
    Benabou, R.
    EPILEPSIA, 2009, 50 : 201 - 201
  • [40] Long-term safety of pregabalin treatment in patients with partial-onset epilepsy: Pooled analysis of six open-label clinical trials
    Uthman, Basim
    Bazil, C.
    Schultze-Bonhage, A.
    Whalen, E.
    Leon, T.
    Emir, B.
    Benabou, R.
    EPILEPSIA, 2007, 48 : 78 - 78
12345